Haibo Wang

Corporate Officer/Principal at HARPOON THERAPEUTICS, INC.

Consumer Services

Health Technology

Commercial Services

Profile

Haibo Wang is a professional who currently holds the position of Senior Vice President-Business Development at Harpoon Therapeutics, Inc. He previously worked as Vice President-Business Development at Hummingbird Bioscience Pte Ltd.
Wang holds an MBA from Duke University, a graduate degree from The Johns Hopkins University, and an undergraduate degree from Tsinghua University.

Haibo Wang active positions

Companies	Position	Start
HARPOON THERAPEUTICS, INC.	Corporate Officer/Principal	31/07/2023

All active positions of Haibo Wang

Former positions of Haibo Wang

Companies	Position	End
Hummingbird Bioscience Pte Ltd. Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore.	Corporate Officer/Principal	-

See the detail of Haibo Wang's experience

Training of Haibo Wang

The Johns Hopkins University	Graduate Degree
Tsinghua University	Undergraduate Degree
Duke University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Haibo Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HARPOON THERAPEUTICS, INC.	Health Technology

Private companies	1
Hummingbird Bioscience Pte Ltd. Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore.	Commercial Services